4-Bromocumene | CAS:586-61-8

We serve 4-Bromocumene CAS:586-61-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Bromocumene

Chemical Name:4-Bromocumene
CAS.NO:586-61-8
Synonyms:P-BROMOCUMENE 
1-BROMO-4-ISOPROPYLBENZENE
Molecular Formula:C9H11Br
Molecular Weight:199.08800
 
Physical and Chemical Properties:
Density:1.286;
Melting point:-22oC;
Boiling point:103-104oC;
Flash point:100oF;
Index of Refraction:1.537;
 
Specification:
Appearance:Light yellow liquid
Purity(HPLC):≥98.5%
Moisture:≤0.5%
Residue on lgnition:≤0.5%
Total Impurnity:≤1.5%
Single impunty:≤1.0%
 
Packing:250 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:As an intermediate in organic synthesis



Contact us for information like 4-Bromocumene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1-BROMO-4-ISOPROPYLBENZENE physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,P-BROMOCUMENE Use and application,P-BROMOCUMENE technical grade,usp/ep/jp grade.


Related News: Three more patients have been confirmed infected with coronavirus in South Korea, bringing the country’s total to 15, the South Korean Centers for Disease Control and Prevention (KCDC) announced in a press release.Benzyl mercaptan manufacturer Since first being reported in the city of Wuhan, where it is believed to have originated at a seafood market, the virus has not provoked unusual symptoms in people who have been diagnosed.Dibutyl maleate supplier In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.(R,R)-2-amino-1-(4-nitrophenyl)propane-1,3-diol vendor As you can see, a considerable number of staff is involved in the production phase until an API is finally manufactured.Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).